The unintended pregnancy rate in America is astoundingly high (nearly 50%) and minority women, particularly Black and Hispanic women are at almost twice the risk of unintended pregnancies as Caucasian. The negative implications of an unintended pregnancy can affect a woman’s social, emotional and financial stability. On a national and worldwide level, unintended pregnancies have… Read more »
Short-term geomagnetic disturbances driven by solar activity have been linked to a broad range of adverse health effects. In this blog, author Carolina Leticia Zilli Vieira discusses her recent article, published in Environmental Health, which looks at the effects of GMD on cardiovascular diseases, myocardial infarction, and stroke in 263 U.S. Cities.
September 10th is World Suicide Prevention Day. As part of Springer Nature’s commitment to the Sustainable Development Goals (SDGs), we are endeavoring to help raise awareness of SDG 3.4.2 – reduce suicide mortality rate. In this blog, Amanda Perry, guest editor of a recent collection in Health & Justice, discusses the important topic of suicide in the criminal justice system. Plus, check out more content we’ve made available in support of World Suicide Prevention Day.
Usually, The Journal of Headache and Pain invites researchers to write about advances in the migraine treatment and report on their research. For this year’s Migraine Awareness Week we wanted to hear the patient’s perspective on improvements in migraine treatment. In this Q&A Victoria Hentschke interviews a colleague who has suffered from migraine for 25 years.
The opioid crisis has claimed over half a million lives in the United States since 1996. In this Q&A, Guohua Li, Editor-in-Chief of the BMC journal Injury Epidemiology, discusses the origins of the epidemic and more recent developments.
On the occasion of the Migraine Awareness Week 2019, we’ve invited Dr. Bianca Raffaelli Junior Fellow of the European Federation School of Advanced Studies (EHF-SAS) to tell us about the influence of sex hormones on migraine and her current research project.
On the occasion of Migraine Awareness Week 2019, we’ve invited Martina Guglielmetti, resident in Internal Medicine at the University of Sassari and junior headache researcher, to tell us more about the so called ‘disease modifying migraine drugs’ and their mode of action. For more details on this topic and on recent advances in migraine treatment, read The Journal of Headache and Pain’s current thematic series ‘The changing face of migraine’.